PDL BioPharma, Inc. Increase (Decrease) in Income Taxes Receivable
PDL BioPharma, Inc. reported Increase (Decrease) in Income Taxes Receivable of -$56.08 million for the 4-month period ending 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2021-03-29
- 2020-12-31: Increase (Decrease) in Income Taxes Receivable 4 month -$56.08M.
- 2020-09-30: Increase (Decrease) in Income Taxes Receivable 1 month -$53.11M.
| Period end | Increase (Decrease) in Income Taxes Receivable 1 month | Increase (Decrease) in Income Taxes Receivable 4 month |
|---|---|---|
| 2020-12-31 | -$56.08M 10-K · filed 2021-03-29 | |
| 2020-09-30 | -$53.11M 10-Q · filed 2020-11-13 |